This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Fecal calprotectin as a biomarker of intestinal graft versus host disease after allogeneic hematopoietic stem cell transplantation
Scientific Reports Open Access 21 January 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Thompson B, Salzman D, Steinhauer J, Lazenby AJ, Wilcox CM . Prospective endoscopic evaluation for gastrointestinal graft-versus-host disease: determination of the best diagnostic approach. Bone Marrow Transplant 2006; 38: 371–376.
Akpek G, Chinratanalab W, Lee L, Toberson M, Hallick J, Anders V et al. Gatrointestinal involment in chronic graft versus host disease: A clinicopathologic study. Biol Blood Marrow Transplant 2003; 9: 46–51.
Shidham VB, Chang CC, Shidham G, Ghazala F, Lindholm PF, Kampalath B et al. Colon biopsies for evaluation of acute graft-versus-host disease (A-GVHD) in allogeneic bone marrow transplant patients. BMC Gastroenterol 2003; 3: 5.
Yui S, Nakatani Y, Mikami M . Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol Pharm Bull 2003; 26: 753–760.
Konikoff MR, Denson LA . Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Dis 2006; 12: 524–534.
Lemann M, Mary JY . Calprotectin and IBD. Gut 2005; 54: 1349–1350.
Haghighi KS, Sharif K, Gupte G, Mirza DF, Mayer AD, Carroll D et al. Evaluation of calprotectin level in intestinal content as an early marker for graft rejection. Transplant Proc 2006; 38: 1733–1734.
Sudan D, Vargas L, Sun Y, Bok L, Dijkstra G, Langnas A . Calprotectin: a novel noninvasive marker for intestinal allograft monitoring. Ann Surg 2007; 246: 311–315.
Kreisel W, Herbst EW, Schwind B, Ochs A, Olschewski M, Köchling G et al. Diagnosis and grading of acute graft-versus-host disease following allogeneic bone marrow transplantation by sigmoidoscopy. Eur J Gastroenterol Hepatol 1994; 6: 723–729.
Kreisel W, Dahlberg M, Bertz H, Harder J, Potthoff K, Deibert P et al. Endoscopic diagnosis of acute intestinal GVHD following allogeneic hematopoietic SCT: a retrospective analysis in 175 patients. Bone Marrow Transplant 2012; 47: 430–438.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Bastos Oreiro, M., Castilla-Llorente, C., de la Guía, A. et al. Fecal calprotectin in allogeneic stem cell transplantation for the diagnosis of acute intestinal graft versus host disease. Bone Marrow Transplant 47, 1241–1242 (2012). https://doi.org/10.1038/bmt.2011.241
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2011.241
This article is cited by
-
Baseline calprotectin fails to predict incidence of acute gastrointestinal graft vs. host disease: a prospective study
Bone Marrow Transplantation (2019)
-
Non-invasive diagnosis of acute intestinal graft-versus-host disease by a new scoring system using ultrasound morphology, compound elastography, and contrast-enhanced ultrasound
Bone Marrow Transplantation (2019)
-
Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation
Annals of Hematology (2017)
-
Endoscopic and Histological Findings Are Predicted by Fecal Calprotectin in Acute Intestinal Graft-Versus-Host-Disease
Digestive Diseases and Sciences (2016)
-
Fecal calprotectin as a biomarker of intestinal graft versus host disease after allogeneic hematopoietic stem cell transplantation
Scientific Reports (2015)